US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Glycerin

Reason Lack of Assurance of Sterility

Advanced Physician Solutions, Inc. D-1097-2015
Class II · Moderate risk Terminated

Glutathione 200mg/Ml

Reason Lack of Assurance of Sterility

Advanced Physician Solutions, Inc. D-1096-2015
Class II · Moderate risk Terminated

Estradiol Valerate

Reason Lack of Assurance of Sterility

Advanced Physician Solutions, Inc. D-1095-2015
Class II · Moderate risk Terminated

Estradiol Valerate

Reason Lack of Assurance of Sterility

Advanced Physician Solutions, Inc. D-1094-2015
Class II · Moderate risk Terminated

Estradiol Cypionate

Reason Lack of Assurance of Sterility

Advanced Physician Solutions, Inc. D-1093-2015
Class II · Moderate risk Terminated

Cyanocobalamin

Reason Lack of Assurance of Sterility

Advanced Physician Solutions, Inc. D-1090-2015
Class II · Moderate risk Terminated

MD-Gastroview

Reason Labeling: incorrect or missing lot number and/or expiration date

Mallinckrodt, Inc. NDC 0019-4816-04 D-1132-2015
Class II · Moderate risk Terminated

Alprostadil

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1128-2015
Class II · Moderate risk Terminated

Trimix

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1127-2015
Class II · Moderate risk Terminated

Trimix

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1126-2015
Class II · Moderate risk Terminated

Trimix

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1125-2015
Class II · Moderate risk Terminated

Trimix

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1124-2015
Class II · Moderate risk Terminated

Hyaluronidase

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1123-2015
Class II · Moderate risk Terminated

Glutathione INHALATION

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1122-2015
Class II · Moderate risk Terminated

Glutathione INHALATION

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1121-2015
Class II · Moderate risk Terminated

Bimix

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1120-2015
Class II · Moderate risk Terminated

Avastin

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1119-2015
Class II · Moderate risk Terminated

Alprostadil

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1118-2015
Class II · Moderate risk Terminated

Alprostadil

Reason Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Montana Compounding Pharmacy D-1117-2015
Class II · Moderate risk Terminated

Famotidine Tablets

Reason CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints.

Allegiant Health D-1134-2015
Class II · Moderate risk Terminated

Zebeta¿

Reason Failed Dissolution Specifications: OOS result during stability testing

Teva Pharmaceuticals USA NDC 51285-061-01 D-1112-2015
Class II · Moderate risk Terminated

Sodium Sulfacetamide 9% and Sulfur 4.5% Wash Kit

Reason Microbial Contamination of Non-Sterile Products: Product failed USP Microbial Limits Test.

Mission Pharmacal Co NDC 44523-0609-23 D-1064-2015
Class II · Moderate risk Terminated

Ortho-Cept

Reason Subpotent Drug

Janssen Pharmaceuticals, Inc. NDC 50458-0196-15 D-1063-2015
Class II · Moderate risk Terminated

Azithromycin 500 mg tablets

Reason cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.

PD-Rx Pharmaceuticals, Inc. D-0561-2016